Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review
GD Lopaschuk, S Verma - Basic to Translational Science, 2020 - jacc.org
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
[HTML][HTML] Risk factors for coronary artery disease
JC Brown, TE Gerhardt, E Kwon - 2020 - europepmc.org
Objectives: Review the risk factors for coronary artery disease. Outline screening
recommendations for coronary artery disease. Identify diet and exercise recommendations …
recommendations for coronary artery disease. Identify diet and exercise recommendations …
Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
M Husain, AL Birkenfeld, M Donsmark… - … England Journal of …, 2019 - Mass Medical Soc
Background Establishing cardiovascular safety of new therapies for type 2 diabetes is
important. Safety data are available for the subcutaneous form of the glucagon-like peptide …
important. Safety data are available for the subcutaneous form of the glucagon-like peptide …
ACC/AHA Versus ESC/ESH on Hypertension Guidelines: JACC Guideline Comparison
G Bakris, W Ali, G Parati - Journal of the American College of Cardiology, 2019 - jacc.org
This study compares the recommendations of the most recent American College of
Cardiology (ACC)/American Heart Association (AHA) and European Society of Cardiology …
Cardiology (ACC)/American Heart Association (AHA) and European Society of Cardiology …
Hypertension in pregnancy: Pathophysiology and treatment
S Braunthal, A Brateanu - SAGE open medicine, 2019 - journals.sagepub.com
Hypertensive disorders of pregnancy, an umbrella term that includes preexisting and
gestational hypertension, preeclampsia, and eclampsia, complicate up to 10% of …
gestational hypertension, preeclampsia, and eclampsia, complicate up to 10% of …
Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association
Although cardiologists have long treated patients with coronary artery disease (CAD) and
concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally been considered just a …
concomitant type 2 diabetes mellitus (T2DM), T2DM has traditionally been considered just a …
[PDF][PDF] 2019 Clinical practice guidelines for type 2 diabetes mellitus in Korea
By providing blood glucose (BG) concentration measurements in an almost continuous-time
fashion for several consecutive days, wearable minimally-invasive continuous glucose …
fashion for several consecutive days, wearable minimally-invasive continuous glucose …
An Effective Model of Diabetes Care and Education: Revising the AADE7 Self-Care Behaviors®
American Association of Diabetes … - The Diabetes …, 2020 - journals.sagepub.com
Purpose The AADE7 Self-Care Behaviors®(AADE7) is a robust framework for self-
management of diabetes and other related conditions, such as prediabetes and …
management of diabetes and other related conditions, such as prediabetes and …
Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis
X Li, NC Weber, DM Cohn, MW Hollmann… - Journal of clinical …, 2021 - mdpi.com
In patients with diabetes, metabolic disorders disturb the physiological balance of
coagulation and fibrinolysis, leading to a prothrombotic state characterized by platelet …
coagulation and fibrinolysis, leading to a prothrombotic state characterized by platelet …
Role of aspirin in primary prevention of cardiovascular disease
C Patrono, C Baigent - Nature Reviews Cardiology, 2019 - nature.com
The benefits of aspirin therapy for the secondary prevention of cardiovascular disease
clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in …
clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in …